DOSSIER · 13F-HR · Q1 2026

JOHNSON & JOHNSON

JOHNSON & JOHNSON's pension fund based in Omaha, NE — $652M in tracked AUM across 16 positions as of Q1 2026.

J&

JOHNSON & JOHNSON·Omaha, NE·Pension Fund

CIK 0000200406 · last filed Mar 31, 2026

Total AUM

$652M

▼ 9.9%

vs prior

Holdings

16

—

positions

Whale Score

78

78

strong

Activity

—

no data

changes this Q

Top sector

Tech

26% weight

concentration

AI Analysis · Q1 2026 · Q1 2026

1. Portfolio Overview

The filing represents a concentrated, high-conviction investment portfolio managed by Johnson & Johnson (JJDC), with a total market value of $301.61 million as of September 30, 2025. The portfolio is characterized by low diversification across the number of tickers (15 holdings) but significant concentration in specific assets. The top three holdings—Nanobiotix S.A., MeiraGTx Holdings plc, and Rapport Therapeutics, Inc.—collectively account for 70.91% of the to...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

01

Protagonist Therapeutics Inc.

$258M2.4M39.6%

02

Nanobiotix S.A.

$174M5.6M26.6%

03

MeiraGTx Holdings plc

$58M6.6M8.8%

04

Rapport Therapeutics, Inc.

$56M1.8M8.6%

05

CVRx, Inc.

$38M4.0M5.8%

06

Contineum Therapeutics Inc.

$26M2.0M4.0%

07

Legend Biotech Corporation

$15M815K2.3%

08

Xencor, Inc.

$9M748K1.4%

09

Procept BioRobotics Corporation

$9M358K1.4%

10

Fate Therapeutics, Inc.

$4M3.4M0.6%

Filing history

Filing history loading…